Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, May 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 63 articles:
HTML format


 

Single Articles

  1. BEDNARSKA O, Icenhour A, Tapper S, Witt ST, et al
    Reduced excitatory neurotransmitter levels in anterior insulae are associated with abdominal pain in irritable bowel syndrome.
    Pain. 2019 Apr 24. doi: 10.1097/j.pain.0000000000001589.
    Abstract    

    Abstract available

  2. CAMILLERI M, Carlson P, Chedid V, Vijayvargiya P, et al
    Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea.
    Clin Transl Gastroenterol. 2019 Apr 26. doi: 10.14309/ctg.0000000000000019.
    Abstract    

    Abstract available

  3. EVERITT H, Landau S, Little P, Bishop FL, et al
    Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Health Technol Assess. 2019;23:1-154.
    Abstract    

    Abstract available

  4. KOUNTOURAS J, Doulberis M, Papaefthimiou A, Polyzos SA, et al
    Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.
    Ann Gastroenterol. 2019;32:318.
    Abstract    



  5. VACHER P, Charlanes A, Chesnel C, Pages A, et al
    [Interest of transcranial stimulation in pelvic and perineal disorders].
    Prog Urol. 2019 Apr 26. pii: S1166-7087(19)30077.
    Abstract    

    Abstract available

  6. CAMILLERI M, Carlson P, Chedid V, Vijayvargiya P, et al
    Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea.
    Clin Transl Gastroenterol. 2019;10:e00019.
    Abstract    

    Abstract available

  7. WINDGASSEN S, Moss-Morris R, Everitt H, Sibelli A, et al
    Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome.
    Behav Ther. 2019;50:594-607.
    Abstract    

    Abstract available

  8. PERALTA-PALMEZANO JJ, Guerrero-Lozano R
    Prevalence of Functional Gastrointestinal Disorders in School Children and Adolescents.
    Korean J Gastroenterol. 2019;73:207-212.
    Abstract    

    Abstract available

  9. STAUDACHER HM, Ralph FSE, Irving PM, Whelan K, et al
    Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
    J Acad Nutr Diet. 2019 Apr 24. pii: S2212-2672(18)31829.
    Abstract    

    Abstract available

  10. SALARI-MOGHADDAM A, Keshteli AH, Esmaillzadeh A, Adibi P, et al
    Empirically derived food-based inflammatory potential of the diet, irritable bowel syndrome, and its severity.
    Nutrition. 2019;63-64:141-147.
    Abstract    

    Abstract available

  11. PENSABENE L, Salvatore S, Turco R, Tarsitano F, et al
    Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.
    J Pediatr (Rio J). 2019 Apr 24. pii: S0021-7557(19)30110.
    Abstract    

    Abstract available

  12. DUNBAR KB
    Gastroenterology for the Internist.
    Med Clin North Am. 2019;103:xvii-xviii.
    Abstract    



  13. JIA Q, Zhang L, Zhang J, Pei F, et al
    Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.
    Biomed Res Int. 2019;2019:4530203.
    Abstract    

    Abstract available

  14. HUANG HL, Chen HT, Luo QL, Xu HM, et al
    Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    J Dig Dis. 2019 May 9. doi: 10.1111/1751-2980.12756.
    Abstract    

    Abstract available

  15. LI Y, Tian X, Li S, Chang L, et al
    Total polysaccharides of adlay bran (Coix lachryma-jobi L.) improve TNF-alpha induced epithelial barrier dysfunction in Caco-2 cells via inhibition of the inflammatory response.
    Food Funct. 2019 May 9. doi: 10.1039/c9fo00590.
    Abstract    

    Abstract available

  16. FITZGERALD E, Murphy S, Martinson HA
    Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease.
    Front Neurosci. 2019;13:369.
    Abstract    

    Abstract available

  17. TACK J, Stanghellini V, Mearin F, Yiannakou Y, et al
    Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
    BMC Gastroenterol. 2019;19:69.
    Abstract    

    Abstract available

  18. KILLIAN LA, Lee SY
    Irritable Bowel Syndrome is Underdiagnosed and Ineffectively Managed Among Endurance Athletes.
    Appl Physiol Nutr Metab. 2019 May 7. doi: 10.1139/apnm-2019-0261.
    Abstract    

    Abstract available

  19. MOHAMMADZADEH N, Kalani BS, Bolori S, Azadegan A, et al
    Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea.
    Acta Microbiol Immunol Hung. 2019 May 7:1-14. doi: 10.1556/030.66.2019.
    Abstract    

    Abstract available

  20. ZHANG Y, Ma ZF, Zhang H, Pan B, et al
    Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia.
    JGH Open. 2018;3:173-178.
    Abstract    

    Abstract available

  21. CHEY WD
    Microbiome-Based Treatment Strategies for Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2019;15:164-166.
    Abstract    



  22. SKODJE GI, Minelle IH, Rolfsen KL, Iacovou M, et al
    Dietary and symptom assessment in adults with self-reported non-coeliac gluten sensitivity.
    Clin Nutr ESPEN. 2019;31:88-94.
    Abstract    

    Abstract available

  23. JI MX, Guo MW, Gao YS, Lan Y, et al
    [Comparison of effects of electroacupuncture at "Tianshu" (ST25) and "Dachangshu" (BL25) on intestinal sensitivity and expression of muscarinic M3R and 5-HT3AR in irritable bowel syndrome rats].
    Zhen Ci Yan Jiu. 2019;44:264-9.
    Abstract    

    Abstract available

  24. MIDENFJORD I, Polster A, Sjovall H, Tornblom H, et al
    Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.
    Neurogastroenterol Motil. 2019 May 5:e13619. doi: 10.1111/nmo.13619.
    Abstract    

    Abstract available

  25. HARTE SE, Schrepf A, Gallop R, Kruger GH, et al
    Quantitative Assessment of Non-Pelvic Pressure Pain Sensitivity in Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network Study.
    Pain. 2019 Jan 29. doi: 10.1097/j.pain.0000000000001505.
    Abstract    

    Abstract available

  26. MCOMBER M, Rafati D, Cain K, Devaraj S, et al
    Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain.
    Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30521.
    Abstract    

    Abstract available

  27. PARFENOV CAPITAL A, CYRILLICI, Belostotsky NI, Khomeriki SG, Akhmadullina OV, et al
    Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study.
    Ter Arkh. 2019;91:25-31.
    Abstract    

    Abstract available

  28. GALLIGAN JJ
    Cannabinoid-induced relief of hypermotility in a rat model of the irritable bowel syndrome.
    Neurogastroenterol Motil. 2019;31:e13613.
    Abstract    

    Abstract available

  29. MEZZASALMA V, Manfrini E, Ferri E, Sandionigi A, et al
    Corrigendum to "A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation".
    Biomed Res Int. 2019;2019:9042956.
    Abstract    

    Abstract available

  30. KANO M, Yoshizawa M, Kono K, Muratsubaki T, et al
    Parasympathetic activity correlates with subjective and brain responses to rectal distension in healthy subjects but not in non-constipated patients with irritable bowel syndrome.
    Sci Rep. 2019;9:7358.
    Abstract    

    Abstract available

  31. RICCIUTO A, Griffiths AM
    Clinical Value of Fecal Calprotectin.
    Crit Rev Clin Lab Sci. 2019 May 15:1-37. doi: 10.1080/10408363.2019.1619159.
    Abstract    

    Abstract available

  32. GUO T, Bian Z, Trocki K, Chen L, et al
    Optical recording reveals topological distribution of functionally classified colorectal afferent neurons in intact lumbosacral DRG.
    Physiol Rep. 2019;7:e14097.
    Abstract    

    Abstract available

  33. ZHANG L, Song Q, Zhang X, Li L, et al
    Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.
    Invest New Drugs. 2019 May 14. pii: 10.1007/s10637-019-00790.
    Abstract    

    Abstract available

  34. LEPRUN PMB, Clarke G
    The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut-brain axis.
    Curr Opin Pharmacol. 2019;49:17-23.
    Abstract    

    Abstract available

  35. CHUNG CF, Wang Q, Schroeder J, Cole A, et al
    Identifying and Planning for Individualized Change: Patient-Provider Collaboration Using Lightweight Food Diaries in Healthy Eating and Irritable Bowel Syndrome.
    Proc ACM Interact Mob Wearable Ubiquitous Technol. 2019;3.
    Abstract    

    Abstract available

  36. PARK YG, Han SY, Chae H, Bae N, et al
    Development and validation of Sasang Urination and Defecation Inventory (SUDI) for pathophysiological symptoms of Sasang typology.
    Integr Med Res. 2019;8:82-88.
    Abstract    

    Abstract available

  37. VAN DEN HOUTE K, Carbone F, Pannemans J, Corsetti M, et al
    Prevalence and impact of self-reported irritable bowel symptoms in the general population.
    United European Gastroenterol J. 2019;7:307-315.
    Abstract    

    Abstract available

  38. EADY SL, Wallace AJ, Butts CA, Hedderley D, et al
    The effect of 'Zesy002' kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial.
    J Nutr Sci. 2019;8:e18.
    Abstract    

    Abstract available

  39. OKAWA Y, Fukudo S, Sanada H
    Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review.
    Biopsychosoc Med. 2019;13:10.
    Abstract    

    Abstract available

  40. LIN X, Liu X, Xu J, Cheng KK, et al
    Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome.
    Chin Med. 2019;14:18.
    Abstract    

    Abstract available

  41. JIANG C, Xu Y, Sharma S, Zhang L, et al
    Association of defecation disorders with suicidal ideation in young adult with chronic abdominal discomfort.
    J Affect Disord. 2019;253:308-311.
    Abstract    

    Abstract available

  42. WILECHANSKY RM, Spring M, Huang Q, Zullow S, et al
    Eosinophilic esophagitis, gastroenteritis, and colitis in a patient with prior parasite exposure.
    Clin J Gastroenterol. 2019 May 10. pii: 10.1007/s12328-019-00988.
    Abstract    

    Abstract available

  43. O'BRIEN R, Buckley MM, Kelliher A, O'Malley D, et al
    PI 3-kinase- and ERK-MAPK-dependent mechanisms underlie Glucagon-Like Peptide-1-mediated activation of Sprague Dawley colonic myenteric neurons.
    Neurogastroenterol Motil. 2019 May 23:e13631. doi: 10.1111/nmo.13631.
    Abstract    

    Abstract available

  44. CLAESSEN JJM, van Es JM, Boermeester MA
    [Abdominal pain].
    Ned Tijdschr Geneeskd. 2019;163.
    Abstract    

    Abstract available

  45. WEERTS ZZRM, Vork L, Mujagic Z, Keszthelyi D, et al
    Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2019 May 22:e13629. doi: 10.1111/nmo.13629.
    Abstract    

    Abstract available

  46. PACHECO RL, Roizenblatt A, Gois AFT, Latorraca COC, et al
    What do Cochrane systematic reviews say about the management of irritable bowel syndrome?
    Sao Paulo Med J. 2019;137:82-91.
    Abstract    

    Abstract available

  47. MELCHIOR C, Desprez C, Houivet E, Debeir LA, et al
    Is abnormal 25 g fructose breath test a predictor of symptomatic response to a low fructose diet in irritable bowel syndrome?
    Clin Nutr. 2019 May 8. pii: S0261-5614(19)30207.
    Abstract    

    Abstract available

  48. GANJI L, Alebouyeh M, Shirazi MH, Zali MR, et al
    Comparative transcriptional analysis for Toll-like receptors, inflammatory cytokines, and apoptotic genes in response to different cytolethal-encoding and noncoding isolates of Salmonella enterica and Campylobacter jejuni from food and human stool.
    Microb Pathog. 2019 May 18:103550. doi: 10.1016/j.micpath.2019.103550.
    Abstract    

    Abstract available

  49. TOKARZ R, Hyams JS, Mack DR, Boyle B, et al
    Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 May 21. pii: 5493583. doi: 10.1093.
    Abstract    

    Abstract available

  50. YAMAMOTO M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P, et al
    Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients.
    Metabolomics. 2019;15:82.
    Abstract    

    Abstract available

  51. YAN J, Miao ZW, Lu J, Ge F, et al
    Acupuncture plus Chinese Herbal Medicine for Irritable Bowel Syndrome with Diarrhea: A Systematic Review and Meta-Analysis.
    Evid Based Complement Alternat Med. 2019;2019:7680963.
    Abstract    

    Abstract available

  52. ELTORKI M, Bhattacharjee A, Khan M, Martin E, et al
    Treatment failure in children diagnosed with constipation in a paediatric emergency department in relation to Rome III criteria.
    Paediatr Child Health. 2019;24:185-192.
    Abstract    

    Abstract available

  53. AGUADO A, Garcia Del Alamo M
    [Gastrointestinal comorbidity and symptoms associated with depression in patients aged over 60 years].
    Semergen. 2019 May 16. pii: S1138-3593(19)30099.
    Abstract    

    Abstract available

  54. ESWARAN S, Dolan RD, Ball SC, Jackson K, et al
    The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea.
    J Acad Nutr Diet. 2019 May 15. pii: S2212-2672(18)31544.
    Abstract    

    Abstract available

  55. ROSETTE C, Agan FJ, Rosette N, Moro L, et al
    Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFkappaB inhibition.
    Drug Metab Pharmacokinet. 2019 Jan 17. pii: S1347-4367(18)30153.
    Abstract    

    Abstract available

  56. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder.
    Am J Gastroenterol. 2017;112:1619-1620.
    Abstract    



  57. SHAUKAT A, Brenner DM
    Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
    Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000259.
    Abstract    

    Abstract available

  58. PAPAEFTHYMIOU A, Doulberis M, Kountouras J, Kolokytha C, et al
    Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.
    Eur J Gastroenterol Hepatol. 2019 May 16. doi: 10.1097/MEG.0000000000001439.
    Abstract    

    Abstract available

  59. FRITSCHER-RAVENS A, Pflaum T, Mosinger M, Ruchai Z, et al
    Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E.
    Gastroenterology. 2019 May 14. pii: S0016-5085(19)34636.
    Abstract    

    Abstract available

  60. GHOSHAL UC, Rahman MM
    Post-infection irritable bowel syndrome in the tropical and subtropical regions: Vibrio cholerae is a new cause of this well-known condition.
    Indian J Gastroenterol. 2019 May 9. pii: 10.1007/s12664-019-00959.
    Abstract    



  61. SIAWASH M, van Assen T, Ten WTA, Jansen L, et al
    Abdominal Wall Pain or Irritable Bowel Syndrome: Validation of a Pediatric Questionnaire.
    J Pediatr Gastroenterol Nutr. 2019 May 2. doi: 10.1097/MPG.0000000000002366.
    Abstract    

    Abstract available

  62. SVENDSEN AT, Bytzer P, Engsbro AL
    Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?
    Scand J Gastroenterol. 2019 May 21:1-17. doi: 10.1080/00365521.2019.1607897.
    Abstract    

    Abstract available

  63. LACKNER J, Weiss M, Muller-Graf C, Greiner M, et al
    The disease burden associated with Campylobacter spp. in Germany, 2014.
    PLoS One. 2019;14:e0216867.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;